HINT1 and neoplasm: Furthermore, a recent study showed that HINT1 is subjected to K21 acetylation and Y109 in activated mast cells, together with Ap4A-mediated HINT1 release from MITF16, suggesting that posttranslational modifications of HINT1 could be a key mechanism for HINT1’s tumor-suppressive role.